Inflammatory markers play a pivotal role in phenotyping asthma, assessing risks, and tailoring personalised therapeutic strategies, particularly in asthma associated with allergic sensitisation ...

Immune checkpoint inhibitors, a class of immunotherapies that help immune cells attack cancer more effectively, have revolutionized cancer treatment. However, fewer than 20% of patients respond to ...

Long-term extension analysis of the phase 3b APEX study (NCT04882098) through 3 years of treatment will further assess the sustained efficacy of guselkumab (Tremfya; Johnson & Johnson) in limiting ...